Reports related to this article:
Project(s): View 3 related projects in PECWeb
Plant(s): View 3 related plants in PECWeb
Released October 07, 2016 | SUGAR LAND
en
Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--There is nothing simulated or subconscious about the financial benefit derived from the $5.6 billion that the life science industry invested in 351 North American projects. These figures represent actual capital and maintenance (MRO) projects that made it off the drawing board, through the boardroom and into construction, all with projected completion dates during the fourth quarter of 2016.
Click on the image at right for a graph detailing North American Pharmaceutical-Biotech Projects to be completed in 4Q16, by region.
Offering a range of investments as diverse as the industry itself, a recent survey of reported projects in Industrial Info's Pharmaceutical Online Database reveals that, cumulatively, the projects deliver an average total investment value of nearly $16 million. Completion schedules are one of the few similarities the projects share, as they run the gamut from regularly scheduled maintenance projects to massive new research laboratories. Sources for the fourth-quarter activity include private industry, commercial developers, institutions and universities. The projects reported involve grassroot facilities, major building additions to existing sites, and in-plant capital. The projects are a varied group in both size and focus.
Johnson & Johnson's (NYSE:JNJ) (New Brunswick, New Jersey) Vision Care division plans to finish a $300 million expansion at its 69-acre, 836,000-square-foot contact lenses manufacturing campus in Jacksonville, Florida. Known as the Phase VII Expansion, the project added another 35,000-square-foot disposable contacts manufacturing unit with five new production lines, along with a materials staging area, a solvent tank farm and other upgrades. The project team included architect Flad and Associates (Gainesville, Florida) and Gilbane Building Company (Jacksonville, Florida).
In Durham, North Carolina, bioMerieux USA anticipates completing a $50 million expansion before the year is done. The project expanded the company's existing 230,000-square-foot plant by 36,000 square feet and added an additional in vitro formulation and filling line. Jacobs Engineering Group (NYSE:JEC) (Pasadena, California) was tapped as the design/build firm for the project.
A look to Canada sees Galderma Production Canada (Thornhill, Ontario) put the finishing touches on a $46 million expansion project in Baie-d'Urfe, Quebec. The project expanded the existing 200,000-square-foot plant by an additional 77,000 square feet and outfitted the new space to expand production of topical creams and ointments (including Cetaphil), from approximately 80 million units per year to approximately 105 million units per year, by adding two production suites and two packaging lines (currently 8 production suites and 9 packaging lines). Architect DFS Incorporated (Montreal, Quebec) was joined on the project team by engineering firm LaPorte Consultants (Montreal) and general contractor EBC incorporated (L'ancienne-Lorette, Quebec).
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn. For more information on our coverage, send inquiries to info@industrialinfo.com or visit us online at http://www.industrialinfo.com.
Click on the image at right for a graph detailing North American Pharmaceutical-Biotech Projects to be completed in 4Q16, by region.Offering a range of investments as diverse as the industry itself, a recent survey of reported projects in Industrial Info's Pharmaceutical Online Database reveals that, cumulatively, the projects deliver an average total investment value of nearly $16 million. Completion schedules are one of the few similarities the projects share, as they run the gamut from regularly scheduled maintenance projects to massive new research laboratories. Sources for the fourth-quarter activity include private industry, commercial developers, institutions and universities. The projects reported involve grassroot facilities, major building additions to existing sites, and in-plant capital. The projects are a varied group in both size and focus.
Johnson & Johnson's (NYSE:JNJ) (New Brunswick, New Jersey) Vision Care division plans to finish a $300 million expansion at its 69-acre, 836,000-square-foot contact lenses manufacturing campus in Jacksonville, Florida. Known as the Phase VII Expansion, the project added another 35,000-square-foot disposable contacts manufacturing unit with five new production lines, along with a materials staging area, a solvent tank farm and other upgrades. The project team included architect Flad and Associates (Gainesville, Florida) and Gilbane Building Company (Jacksonville, Florida).
In Durham, North Carolina, bioMerieux USA anticipates completing a $50 million expansion before the year is done. The project expanded the company's existing 230,000-square-foot plant by 36,000 square feet and added an additional in vitro formulation and filling line. Jacobs Engineering Group (NYSE:JEC) (Pasadena, California) was tapped as the design/build firm for the project.
A look to Canada sees Galderma Production Canada (Thornhill, Ontario) put the finishing touches on a $46 million expansion project in Baie-d'Urfe, Quebec. The project expanded the existing 200,000-square-foot plant by an additional 77,000 square feet and outfitted the new space to expand production of topical creams and ointments (including Cetaphil), from approximately 80 million units per year to approximately 105 million units per year, by adding two production suites and two packaging lines (currently 8 production suites and 9 packaging lines). Architect DFS Incorporated (Montreal, Quebec) was joined on the project team by engineering firm LaPorte Consultants (Montreal) and general contractor EBC incorporated (L'ancienne-Lorette, Quebec).
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn. For more information on our coverage, send inquiries to info@industrialinfo.com or visit us online at http://www.industrialinfo.com.
